Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term sirolimus pretreatment to prevent acute GVHD in elderly HSCT recipients
2008-002310-22Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sirolimus in graft-versus-host disease (GVHD) and Bone marrow transplant rejection (BMR), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Incidence of grade II-IV acute graft-versus-host disease. Started Jun 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
graft-versus-host disease (GVHD)Bone marrow transplant rejection (BMR)
Beyond the preview
Go deeper on 2008-002310-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002310-22.